Loading…
Qualitek Labs (BSE 544091)₹532.50+0.22%Consulting Services
In the Mar 2026 quarter (consolidated), Qualitek Labs reported sales of ₹70.02 Cr and net profit of ₹9.97 Cr. For the year to Mar 2026, sales were ₹125 Cr and net profit ₹14.96 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Sep 2025 | Mar 2026 | |
|---|---|---|
| Sales | 54.03 | 70.02 |
| Expenses | 42.85 | 51.79 |
| Operating Profit | 10.96 | 17.94 |
| OPM % | 21.0% | 25.9% |
| Other Income | 0.00 | 0.00 |
| Interest | 2.01 | 3.01 |
| Depreciation | 2.99 | 3.99 |
| Profit before tax | 5.99 | 11.98 |
| Tax % | 26.1% | 17.1% |
| Exceptional items | 0.00 | −0.06 |
| Net Profit | 4.99 | 9.97 |
| EPS (Rs) | 4.10 | 8.47 |
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 5.99 | 12.01 | 69.96 | 125 |
| Expenses | 5.98 | 10.96 | 53.78 | 94.61 |
| Operating Profit | 0.99 | 0.99 | 15.94 | 28.91 |
| OPM % | 11.0% | 10.0% | 23.0% | 23.9% |
| Other Income | 0.00 | 0.00 | 1.01 | 0.00 |
| Interest | 0.00 | 0.00 | 2.01 | 5.01 |
| Depreciation | 0.00 | 0.99 | 3.99 | 6.98 |
| Profit before tax | 0.00 | 0.00 | 9.99 | 17.98 |
| Tax % | 61.1% | 12.1% | 26.1% | 20.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.00 | 0.00 | 7.97 | 14.96 |
| EPS (Rs) | 160.61 | 9.16 | 6.33 | 12.58 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.02 | 0.47 | 10.03 | 12.04 |
| Reserves | −0.99 | 0.00 | 76.88 | 141 |
| Borrowings | 10.97 | 16.98 | 49.89 | 92.86 |
| Other Liabilities | 4.02 | 3.01 | 21.10 | 26.12 |
| Total Liabilities | 14.01 | 21.00 | 158 | 271 |
| Fixed Assets | 5.99 | 7.98 | 91.80 | 152 |
| CWIP | 4.01 | 4.01 | 16.05 | 45.12 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.01 | 9.01 | 50.05 | 72.99 |
| Inventories | 0.00 | 0.00 | 2.64 | 3.17 |
| Trade receivables | 1.21 | 2.21 | 28.98 | 42.29 |
| Cash & equivalents | 0.15 | 1.04 | 5.18 | 6.06 |
| Total Assets | 14.01 | 21.00 | 158 | 271 |
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 1.01 | −5.02 | 10.04 | 15.06 |
| Cash from investing activity | −6.02 | −2.01 | −60.21 | −51.20 |
| Cash from financing activity | 5.02 | 7.03 | 54.19 | 37.14 |
| Net cash flow | 0.00 | 0.00 | 3.98 | 0.99 |
| Capex | 6.05 | 1.76 | 11.79 | 13.28 |
| Free cash flow | −5.01 | −7.02 | −13.02 | −32.06 |
| CFO / OP % | 244.0% | −363.0% | 74.9% | 67.0% |
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 70 | 68 | 151 | 125 |
| Inventory days | — | — | — | 70 |
| Days payable | — | — | — | 206 |
| Cash conversion cycle | 69 | 67 | 150 | −13 |
| Working capital days | −700 | −431 | 26 | −9 |
| ROCE % | — | 6.0% | — | 12.0% |
For the Mar 2026 quarter, Qualitek Labs reported sales of ₹70.02 Cr and net profit of ₹9.97 Cr. The operating margin was 25.9%.
Qualitek Labs' sales for the year to Mar 2026 were ₹125 Cr.
Net profit for the year to Mar 2026 was ₹14.96 Cr. Earnings per share over the same trailing period were ₹12.58.
Qualitek Labs reported borrowings of ₹92.86 Cr at Mar 2026, against cash and equivalents of ₹6.06 Cr.
Cash from operations was ₹15.06 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹32.06 Cr.